|
|
Biochemist and protein engineer Vanessa Small has broad expertise in the development and commercial-ization of point-of-care diagnostics. She is Head of Bio-logics at Cue Health (a privately held healthcare technology company developing products for molecular diagnostics and biochemical screening). Throughout her 20-year career, Vanessa has served as a thought leader and technical expert, advising on topics pertaining to bio-pharmaceutical analysis and CMC development. As an accomplished scientist, she has developed novel antibodies, enzymes, and molecular diagnostic assay reagents generating over $1B in revenue. Vanessa has held key scientific roles and senior management positions in several biotechnology companies, including Pfizer, CalAsia Pharmaceuticals (acquired by Collidon), Alere Health (acquired by Abbott), and Cue Health Inc.
Resourceful, and engaging biochemist with over twenty years of industry experience, who specializes in building relationships and championing change to drive results. Accomplished R&D, Process & Product Development, Tech Transfer, Manufacturing Operations, Quality, and Project Leader with a strong technical background and demonstrated success in leading teams to reliably meet or exceed timelines; productivity requirements; and quality goals. Excellent team builder and implementer creating alignment to bring about key business results.
Resourceful, and engaging biochemist with over twenty years of industry experience, who specializes in building relationships and championing change to drive results. Accomplished R&D, Process & Product Development, Tech Transfer, Manufacturing Operations, Quality, and Project Leader with a strong technical background and demonstrated success in leading teams to reliably meet or exceed timelines; productivity requirements; and quality goals. Excellent team builder and implementer creating alignment to bring about key business results.
